Heavy-Looking Eyes After Toxin: Causes and Management

Few complaints are as frequent and as avoidable as the "heavy look" after botulinum toxin in the upper third. The patient comes back a week later, with no forehead lines but with a lower brow, an eyelid that looks tired and the feeling that her face "got stiff". Almost always the problem is not the toxin itself, but the balance between the muscles that lift and those that lower the area.

This page is a review for professionals. It has no doses, number of injections or description of points. The foundation of toxin is in botulinum toxin: fundamentals, and functional anatomy in muscle map for botulinum toxin.

Why does the look become heavy?

The most common explanation is loss of the lifting support of the frontalis. The frontalis muscle is the only relevant brow elevator. It works against the muscles that lower the brow: the corrugator, the procerus, the depressor supercilii and the upper portion of the orbicularis oculi. When the glabella is treated, the balance tends to favor the frontalis, which is usually desirable. When the frontalis is weakened more than necessary, the scale tips and the brow drops.

Four situations repeat:

1. Overtreated frontalis, in extent or intensity beyond what the case needs.
2. Frontalis treated in a patient who uses it to compensate for excess eyelid skin (dermatochalasis), brow ptosis or a heavy eyelid.
3. Imbalance between the thirds of the muscle, leaving the lateral portion unopposed and accentuating the drop of the brow tail.
4. Unfavorable prior structure, such as a low brow, a short forehead or eyelids with little tone.

These scenarios explain why the same amount of toxin produces different results in different patients. Assessment matters more than the recipe.

Brow drop or eyelid ptosis?

The distinction is crucial, because causes and ways out are different.

Eyelid ptosis has its own page: ptosis after botulinum toxin and eyelid ptosis vs. brow ptosis. What matters here is identifying which of the two pictures you are facing, because the patient usually describes both as a "droopy eye".

How to assess before treating the frontalis

Prevention starts at the first visit. A short script greatly reduces the chance of a heavy look.

1. Baseline brow position at rest, in the brow position and relative to the orbital rim.
2. Compensatory use test: ask the patient to fully relax the forehead and watch whether the eyelid drops or the field of vision narrows. Someone who lifts the brow to see better is a candidate for a very conservative approach or for avoiding the frontalis.
3. Excess eyelid skin: observe and palpate. See tired-looking eyes: assessment.
4. Symmetry: prior brow and eyelid asymmetries become more evident after toxin.
5. Expectation: some patients want a "frozen" forehead, and others want naturalness. Aligning this avoids frustration. See botulinum toxin in the frontalis muscle.
6. History: prior reactions to toxin and previous procedures in the area.

Management when the look has already become heavy

At review level, management depends on the type of picture.

Brow drop from a weakened frontalis. The toxin effect is reversible and tends to fade over weeks. In the meantime, the professional can guide the patient, explain what to expect and consider camouflage measures. Some professionals consider rebalancing approaches, and the decision on any new injection should be cautious and individualized. See botulinum toxin in the brow.

Eyelid ptosis from diffusion. Management usually involves eye drops prescribed by an ophthalmologist that activate auxiliary eyelid muscles, temporarily. The indication and directions for use belong to the physician. If there is diagnostic doubt or visual symptoms, refer. See ptosis after botulinum toxin.

Low brow without ptosis, in a patient with excess skin. In these cases the professional can discuss other lifting strategies with the patient, such as thread lifts or assessment by a surgeon. See PDO threads in the brow, keeping in mind that they are not a solution for every case.

Prevention: design matters more than quantity

Some conservative ideas are often cited in reviews and consensus statements.

• Individualize. The frontalis of a person with a low brow should not be treated like that of someone with a high brow.
• Balance with the glabella. Treating the depressors tends to help lift the brow, which protects against a heavy look. See botulinum toxin: glabellar complex.
• Preserve the lower third of the frontalis when the brow is low, at the professional's discretion.
• Avoid treating the lateral portion aggressively, so as not to accentuate the drop of the brow tail.
• Consider age and skin: with aging, dependence on the frontalis increases. See aging of the forehead and brow.
• Document with photos before, at follow-up and at review.

It is also important to remember adjacent effects: brow drop can come with headache, eye fatigue and worse perception of lines around the eye. See headache after botulinum toxin.

Talking to the patient

A patient with a heavy look often swings between irritation and embarrassment about leaving the house. Communication needs to be direct, blame no one and come with a plan.

Record the case in the patient record with photos and measurements. See patient records and documentation in HOF and complications with botulinum toxin.

In Harmy

Summary

A heavy look after toxin usually comes from a frontalis weakened more than necessary, in patients who used it to compensate. Separate brow drop from eyelid ptosis, assess beforehand and preserve the frontalis when the eyelid or brow calls for it. If the picture appears, it is reversible, should be followed with photos and a frank conversation, and true ptosis goes to the ophthalmologist.